Statistics for Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials
Total visits
| views | |
|---|---|
| Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials | 97 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| Orkin2020Three-AAM.pdf | 1084 |
Top country views
| views | |
|---|---|
| United States | 68 |
| South Korea | 13 |
| Canada | 2 |
| Sweden | 2 |
| China | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 39 |
| Fairfield | 10 |
| Ann Arbor | 5 |
| Houston | 4 |
| Baltimore | 3 |
| Cambridge | 3 |
| Seoul | 3 |
| Toronto | 2 |
| Beijing | 1 |
| Lakewood | 1 |
| Seremban | 1 |
| Umeå | 1 |